1316 related articles for article (PubMed ID: 25818339)
1. Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
Vinay DS; Ryan EP; Pawelec G; Talib WH; Stagg J; Elkord E; Lichtor T; Decker WK; Whelan RL; Kumara HMCS; Signori E; Honoki K; Georgakilas AG; Amin A; Helferich WG; Boosani CS; Guha G; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Keith WN; Bilsland A; Bhakta D; Halicka D; Fujii H; Aquilano K; Ashraf SS; Nowsheen S; Yang X; Choi BK; Kwon BS
Semin Cancer Biol; 2015 Dec; 35 Suppl():S185-S198. PubMed ID: 25818339
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive strategies that are mediated by tumor cells.
Rabinovich GA; Gabrilovich D; Sotomayor EM
Annu Rev Immunol; 2007; 25():267-96. PubMed ID: 17134371
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer.
Toor SM; Elkord E
Immunol Cell Biol; 2018 Oct; 96(9):888-897. PubMed ID: 29635843
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs.
Whiteside TL; Mandapathil M; Szczepanski M; Szajnik M
Bull Cancer; 2011 Feb; 98(2):E25-31. PubMed ID: 21339097
[TBL] [Abstract][Full Text] [Related]
5. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
6. The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis.
Samec M; Liskova A; Koklesova L; Samuel SM; Murin R; Zubor P; Bujnak J; Kwon TK; Büsselberg D; Prosecky R; Caprnda M; Rodrigo L; Ciccocioppo R; Kruzliak P; Kubatka P
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3137-3154. PubMed ID: 33063131
[TBL] [Abstract][Full Text] [Related]
7. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
8. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
Stewart TJ; Smyth MJ
Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of immune escape of cancer and its regulation.
Morita R; Hirohashi Y; Torigoe T
Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
[No Abstract] [Full Text] [Related]
10. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
11. Suppression, subversion and escape: the role of regulatory T cells in cancer progression.
Oleinika K; Nibbs RJ; Graham GJ; Fraser AR
Clin Exp Immunol; 2013 Jan; 171(1):36-45. PubMed ID: 23199321
[TBL] [Abstract][Full Text] [Related]
12. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
13. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors.
Arens R
Adv Immunol; 2012; 114():217-43. PubMed ID: 22449784
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cells Orchestrate Similar Immune Evasion of Fetuses and Tumors in Mice.
Nehar-Belaid D; Courau T; Dérian N; Florez L; Ruocco MG; Klatzmann D
J Immunol; 2016 Jan; 196(2):678-90. PubMed ID: 26643476
[TBL] [Abstract][Full Text] [Related]
15. Strategies of tumor immune evasion.
Seliger B
BioDrugs; 2005; 19(6):347-54. PubMed ID: 16392887
[TBL] [Abstract][Full Text] [Related]
16. Emerging strategies in regulatory T-cell immunotherapies.
Gajewski TF; Chesney J; Curriel TJ
Clin Adv Hematol Oncol; 2009 Jan; 7(1):1-10; quiz 11-2. PubMed ID: 19288606
[TBL] [Abstract][Full Text] [Related]
17. [Treg cell contribution to anti-CTLA-4 therapeutic effect].
Thierry K; Ménétrier-Caux C
Med Sci (Paris); 2020 Jan; 36(1):73-76. PubMed ID: 32014102
[No Abstract] [Full Text] [Related]
18. Mechanisms of immune evasion by gliomas.
Rolle CE; Sengupta S; Lesniak MS
Adv Exp Med Biol; 2012; 746():53-76. PubMed ID: 22639159
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic growth factor signaling mediating tumor escape from cellular immunity.
Concha-Benavente F; Ferris RL
Curr Opin Immunol; 2017 Apr; 45():52-59. PubMed ID: 28208102
[TBL] [Abstract][Full Text] [Related]
20. T regulatory cells in cancer: recent advances and therapeutic potential.
Elkord E; Alcantar-Orozco EM; Dovedi SJ; Tran DQ; Hawkins RE; Gilham DE
Expert Opin Biol Ther; 2010 Nov; 10(11):1573-86. PubMed ID: 20955112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
